Low potency of fecal immunological surveillance testing soon after negative colonoscopy or resection of low-risk adenoma in average-risk patients.
Kusunoki R, Fujishiro H, Suemitsu S, Kataoka M, Fujiwara A, Tsukano K, Kotani S, Ogawa S, Yamanouchi S, Aimi M, Tanaka M, Ito S, Miyaoka Y, Miyake T, Kohge N, Imaoka T, Ohnuma H, Kinoshita Y, Ishihara S.
Kusunoki R, et al. Among authors: aimi m.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e933-e938. doi: 10.1097/MEG.0000000000002310.
Eur J Gastroenterol Hepatol. 2021.
PMID: 34750324